A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depression
Singleton S. Parker, Sevchik Brooke L., Lahey Analiese, Cuijpers Pim, Harrer Mathias, Jones Megan T., Nayak Sandeep M., Strain Eric C., Vandekar Simon N., Dworkin Robert H., Scott J. Cobb, Satterthwaite Theodore D.
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (65)
- Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials. 2026-01-01 · Expand citations
- Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial. 2025-09-01 · Expand citations
- Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial. 2025-07-24 · Expand citations
- Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis. 2025-07-01 · Expand citations
- Randomized Controlled Trials of Psilocybin-Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis. 2025-05-01 · Expand citations
- Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial. 2025-01-01 · Expand citations
- Quality of reporting on psychological interventions in psychedelic treatments: a systematic review. 2025-01-01 · Expand citations
- Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic: A Randomized Clinical Trial. 2024-12-02 · Expand citations
- Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis. 2024-08-21 · Expand citations
- Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis. 2024-05-01 · Expand citations
- Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin. 2024-03-08 · Expand citations
- Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults - A Systematic Review. 2024-02-29 · Expand citations
- Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials. 2024-01-01 · Expand citations
- Is Poorly Assisted Psilocybin Treatment an Increasing Risk? 2024-01-01 · Expand citations
- Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy. 2024-01-01 · Expand citations
- Must Psilocybin Always "Assist Psychotherapy"? 2024-01-01 · Expand citations
- Psilocybin Without Psychotherapy: A Cart Without a Horse? 2024-01-01 · Expand citations
- Psilocybin for major depressive disorder: a systematic review of randomized controlled studies. 2024-01-01 · Expand citations
- Psychological Support for Psilocybin Treatment: Reply to Letters on Our Commentary. 2024-01-01 · Expand citations
- Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and Necessary 2024-01-01 · Expand citations
- The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov. 2024-01-01 · Expand citations
- Psilocybin-assisted therapy for depression: A systematic review and meta-analysis. 2023-11-01 · Expand citations
- Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial. 2023-09-05 · Expand citations
- Psychotherapy with Psilocybin for Depression: Systematic Review. 2023-03-31 · Expand citations
- Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis. 2023-02-01 · Expand citations
- Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial. 2023-02-01 · Expand citations
- Psychedelic Drug Legislative Reform and Legalization in the US. 2023-01-01 · Expand citations
- Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. 2022-11-03 · Expand citations
- Expectancy in placebo-controlled trials of psychedelics: if so, so what? 2022-10-01 · Expand citations
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. 2021-05-01 · Expand citations
- Trial of Psilocybin versus Escitalopram for Depression. 2021-04-15 · Expand citations
- Psychedelic Psychiatry's Brave New World. 2020-04-02 · Expand citations
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
- Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. 2011-01-01 · Expand citations
- 10.1001/archpsyc.1984.01790140028003
- 10.1001/archpsyc.64.4.419
- 10.1001/jamapsychiatry.2025.4809
- 10.1002/jrsm.1475
- 10.1002/sim.1482
- 10.1002/sim.2514
- 10.1007/s11121-021-01246-3
- 10.1007/s11920-007-0061-3
- 10.1007/s40273-021-01040-7
- 10.1016/j.eclinm.2025.103149
- 10.1038/s41386-023-01755-5
- 10.1038/s44220-024-00373-4
- 10.1056/nejmoa051688
- 10.1080/17512433.2021.1951473
- 10.1136/bmj.315.7109.629
- 10.1136/ebmental-2019-300117
- 10.1176/ajp.2006.163.4.611
- 10.1176/appi.ajp.163.1.28
- 10.1176/appi.ajp.20230643
- 10.1176/appi.ajp.20230667
- 10.1177/070674371005500304
- 10.1177/20451253231198466
- 10.18637/jss.v036.i03
- 10.18637/jss.v093.i06
- 10.3102/10769986030003261
- 10.31234/osf.io/7tbrm
- 10.31234/osf.io/caup9_v1
- 10.4088/jcp.20m13699
- 10.5281/zenodo.15714852
- 10.6028/jres.087.022
Cited by — these papers cite this paper (4)
- Psilocybin in Treatment-Resistant Depression: Weighing Rapid Antidepressant Effects Against Uncertain Durability 2026-10-19 · Expand citations
- Ayahuasca and Salvia divinorum as contrasting modes of consciousness reorganization: Implications for psychedelic-assisted psychotherapy 2026-08-13 · Expand citations
- Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026) 2026-08-12 · Expand citations
- Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health Symptoms 2026-07-01 · Expand citations